Testing effectiveness (Phase 2)Study completedNCT02166268
What this trial is testing
Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
Who this might be right for
Grass Pollen Induced Allergic Rhinoconjunctivitis
ALK-Abelló A/S 140